CClinicalTrials.gg
Status unknownNCT04295668PAPRIKAUpdated Mar 4, 2020

PAPRIKA - Patients Empowerment for Major Surgery Preparation @Home

An observational study in Cancer and Surgical Procedure, Unspecified, sponsored by Hospital Clinic of Barcelona. Status unknown at 1 site in Spain. Per ClinicalTrials.gov, last updated 2020-03-04.

Sponsored by Hospital Clinic of Barcelona · Observational

The sponsor has not verified this record recently (last verified Mar 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
300
Sex
All
01

Study summary

PAPRIKA establishes a technologically enabled and personalized prehabilitation and follow-up after surgical intervention program for patients undergoing elective major surgery Program creates close collaboration between the medical environment and the patients empowering them to co-create their own care.

It is at the first stage aimed to high-risk patients undergoing major surgery. Better condition before the surgery is proved to reduce the perioperative complications and to improve patients' health-related quality of life while cutting the associated costs. The concept integrates short-term (average 4 weeks) preoperative interventions including endurance training, promotion of physical activity and nutritional and psychological support. Interventions are planned both at community and at hospital reducing unnecessary interactions between patients and tertiary care.

PAPRIKA tackles three major drivers: i) human perspective ii) organizational challenges and iii) technical aspects. The project is based on previous experience on prehabilitation and the already refined service using design thinking methodologies. It will be also based on the proven reduction of associated costs for the healthcare system.

02

Conditions studied

  • Cancer
  • Surgical Procedure, Unspecified

Keywords

  • Prehabilitation
  • Exercise training
  • Physical activity
  • Nutrition
  • Cognitive behavioural therapy
  • Smoking cessation
  • eHealth
03

In context

Lead sponsor

Hospital Clinic of Barcelona is the lead sponsor of 319 studies on the registry; 55 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Prospective sample of risk patients who are candidates for major surgery attended in the outpatient offices of the Hospital Clínic de Barcelona.

Inclusion criteria

  • Age > 70 years old and/or American Society of Anesthesiologist (ASA) index 3-4 and/or highly aggressive surgery or solid organ transplantation.

Exclusion criteria

Exclusion Criteria:

  • Non-elective surgery; metastatic disease.
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
300 participants (estimated)
Target follow-up
8 Weeks
Patient registry
Yes

Groups and cohorts

  • Usual care

    A contemporaneous control group of patients was build using propensity score matching (PSM) methodologies taking into account the following matching variables: type of surgery, age, sex, American Society of Anesthesiologists Index (ASA) and adjusted morbidity groups (GMA) grading.

    Behavioral: Usual care

  • Prehabilitation

    Prospective sample of risk patients who are candidates for major surgery attended in the outpatient offices of the Hospital Clínic de Barcelona. Inclusion criteria: i) American Society of Anesthesiologists Index (ASA) 3-4; and / or, ii) age ≥ 75 years; and / or iii) major aggressive surgery; and, iv) solid organ transplant candidate. Exclusion criteria: i) Non-elective surgery; ii) Known metastatic disease before surgery; iii) Unstable respiratory or heart disease; or, iv) Locomotive or cognitive limitations that prevent adherence to the program.

    Behavioral: Prehabilitation

Interventions

  • BehavioralUsual care

    The preoperative standard measures consist of physical activity recommendation and advice on both smoking cessation and alcohol intake reduction. Moreover, in patients presenting with anemia, the anesthesiologists will assess its etiology and treat it accordingly, and nutritional intervention will be performed by a registered dietitian in to those patients at risk of malnutrition (Malnutrition Universal Screening Tool ≥2).

  • BehavioralPrehabilitation

    i) Exercise training: Ambulatory exercise training sessions with two main components, namely: high-intensity endurance exercise training and strength muscular training. ii) Promotion of physical activity: Pedometer-based program using a physical activity tracker linked to a mobile app. iv) Nutritional optimization: Recommendations of a healthy balanced diet or adapted to their digestive symptoms. Daily amount of protein intake will be close to 2 g•Kg-1•day-1. iv) Smoking cessation: Use of both cognitive behavioral intervention and pharmacological therapy by varenicline or nicotine replacement therapies. v) Cognitive behavioral therapy: Weekly group sessions conducted by a clinical health psychologist, including psychoeducation, motivational and behavioral change, self-efficacy and adherence enhancement, coping strategies acquisition and patient empowerment.

06

What researchers measure

Primary outcomes

  1. Postoperative complications

    Number of postoperative complications during the initial hospitalization for surgery

    Time frame: Duration of the initial hospitalization for surgery

  2. Hospital length of stay

    Number of days of hospital length of stay during the initial hospitalization for surgery

    Time frame: Duration of the initial hospitalization for surgery

  3. Severity of postoperative complications

    Severity of postoperative complications during the initial hospitalization for surgery using the Clavien-Dindo classification

    Time frame: Duration of the initial hospitalization for surgery

Secondary outcomes

  1. Hospital readmissions at 30 days

    Number of postoperative complications during a 30-day period after surgery

    Time frame: From initial hospital discharge to 30 days follow-up

  2. Emergency room visits at 30 days

    Number of emergency room visits during a 30-day period after surgery

    Time frame: From initial hospital discharge to 30 days follow-up

  3. Surgical reinterventions at 30 days

    Number of surgical reinterventions during a 30-day period after surgery

    Time frame: From initial hospital discharge to 30 days follow-up

  4. Mortality at 30 days

    Number of exitus during a 30-day period after surgery

    Time frame: From initial hospital discharge to 30 days follow-up

Other outcomes

  1. Six-minute walk test

    Distance covered during the six-minute walk test

    Time frame: At program inclusion and at program discharge (on average at 6 weeks)

  2. Physical activity

    Physical activity measured by the Yale Physical Activity Survey (YPAS) (range 0 to 142; the lowest the worst)

    Time frame: At program inclusion and at program discharge (on average at 6 weeks)

  3. Psycho-emotional status

    Psycho-emotional status measured by the Hospital Anxiety and Depression (HAD) scale (range 0-21; the highest the worst)

    Time frame: At program inclusion and at program discharge (on average at 6 weeks)

07

Study locations

1 of 1 sites recruiting
  • Hospital Clínic de Barcelona
    Barcelona, Catalonia 08036, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 4, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04295668
Lead sponsor
Hospital Clinic of Barcelona
Responsible party
Anael Barberan-Garcia (Principal investigator, Hospital Clinic of Barcelona) — Principal investigator
First posted
Mar 4, 2020
Start date
Jan 1, 2020
Primary completion
Jun 30, 2020 (estimated)
Completion
Jul 30, 2020 (estimated)
Last update
Mar 4, 2020

Study contacts

Anael Barberan-Garcia, PhD
Contact
anaelbg@gmail.com
+34 932775540
Josep Roca, Prof
study director · Hospital Clinic of Barcelona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion